NCT03957902View on ClinicalTrials.gov

Assessment of Direct Biomarkers of Aspirin Action to Develop a Precision Chemoprevention Therapy of Colorectal Cancer

PHASE2RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 6, 2019

Primary Completion Date

May 31, 2025

Study Completion Date

June 30, 2025

Conditions
Colorectal Cancer
Interventions
DRUG

acetylsalicylic acid

Different dosage effect over platelet COX enzymes, non- neoplastic and neoplastic colonic tissues used as biomarkers of clinical efficacy in CRC chemoprevention

Trial Locations (1)

50009

RECRUITING

Hospital Clínico Universitario Lozano Blesa, Zaragoza

All Listed Sponsors
collaborator

Instituto de Salud Carlos III

OTHER_GOV

collaborator

G. d'Annunzio University

OTHER

collaborator

Hospital Clínico Universitario Lozano Blesa

OTHER

lead

Instituto de Investigación Sanitaria Aragón

OTHER